LV dysfunction
There is also growing evidence that concomitant therapy with a       beta-blocker and an ACE inhibitor may reduce mortality rates beyond that observed       with ACE inhibitors alone in survivors of MI who have LV dysfunction.
There is also growing evidence that concomitant therapy with a       beta-blocker and an ACE inhibitor may reduce mortality rates beyond that observed       with ACE inhibitors alone in  @OBJECT$  of MI who  @PREDICAT$   @SUBJECT$ .